Font Size: a A A
Keyword [mutation status]
Result: 81 - 93 | Page: 5 of 5
81. Application Of CT Radiomics Features To Predict The EGFR Mutation Status And Therapeutic Sensitivity To TKIs Of Advanced Lung Adenocarcinoma
82. Effects Of Different Histological Types And Mutation Status On The Efficacy Of Combined Treatment Of NSCLC
83. Analysis Of EGFR Gene Mutation Status In Patients With Advanced Lung Adenocarcinoma After First-line EGFR-TKIs Targeted Therapy And Its Relationship With Efficacy And Prognosis
84. Comparison Of NGS Gene Mutation Status And Influencing Factors In The Blood And Tissue Of Patients With Stage Ⅳ Non-small Cell Lung Cancer
85. Comparative Analysis Of Mutation Status And Immune Landscape For Squamous Cell Carcinoma At Different Anatomical Sites
86. Application Of CT-based Radiomics In Predicting EGFR Mutation Status And Subtypes In Non-small Cell Lung Cancer
87. The Study Of The Relationship Between EGFR Gene Mutation Status And The Efficacy Of First-line Chemotherapy In Patients With Advanced Lung Adenocarcinoma
88. Predictive Value Of A Model Constructed Based On 18F-FDG PET/CT Radiomics Features And Clinical Factors For EGFR Mutation Status In Lung Adenocarcinoma
89. Evaluation Of C-KIT Exon 11 Mutation Status In Gastrointestinal Stromal Tumors By Energy Spectrum CT
90. Value Of Radiomics In The Assessment Of EGFR Gene Mutation Status In Lung Cancer Liver Metastases
91. Radiomics Study For Predicting Bone Metastases And EGFR Mutation Status In Non-small Cell Lung Cancer
92. Predicting The EGFR Mutation Status In Patients With Non-small Cell Lung Cancer Based On Deep Learning And Radiomics
93. Combination Of 18F-FDG PET/CT Radiomics And Clinical Features To Predict EGFR Gene Mutation Status In Lung Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to